久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Deals this week: Swedish Orphan Biovitrum, Vectura pharmaceutical
    November 19, 2018
    Swedish Orphan Biovitrum?(Sobi) has entered an agreement to purchase the US rights for Synagis from AstraZeneca for $1.5bn.
  • AstraZeneca divests US rights to Synagis pharmatimes
    November 14, 2018
    Swedish Orphan Biovitrum AB has entered into an agreement to buy US rights to AstraZeneca’s Synagis, licensed for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service